Inmune Bio Stock Investor Sentiment

INMB Stock  USD 9.22  0.16  1.77%   
About 56% of all INmune Bio's investors are looking to take a long position. The analysis of the overall investor sentiment regarding INmune Bio suggests that some traders are interested. The current market sentiment, together with INmune Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use INmune Bio stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at simplywall.st         
INmune Bio Second Quarter 2024 Earnings US0.51 loss per share
Simply Wall St News at Macroaxis
over six months ago at finance.yahoo.com         
INmune Bio Second Quarter 2024 Earnings US0.51 loss per share
Yahoo News
over six months ago at investing.com         
Earnings call INmune Bio Reports Progress in Oncology and Alzheimers Trials
Investing News at Macroaxis
over six months ago at globenewswire.com         
INmune Bio Inc. Announces Second Quarter 2024 Results and Provides Business Update
Macroaxis News: globenewswire.com
over six months ago at seekingalpha.com         
INmune Bio Q2 2024 Earnings Preview
seekingalpha News
over six months ago at globenewswire.com         
INmune Bio Inc. Announces New Phase 1 Study Data Demonstrating Dose-Dependent Effect of XPro on Prot...
Macroaxis News: globenewswire.com
over six months ago at news.google.com         
INmune Bio Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
Google News at Macroaxis
over six months ago at finance.yahoo.com         
INmune Bio Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on Th...
Yahoo News
over six months ago at finance.yahoo.com         
INmune Bio Inc. Publishes Novel Biology on Natural Killer Cancer Immunotherapy INKmune in the Journa...
Yahoo News
over six months ago at globenewswire.com         
INmune Bio Inc. Publishes Novel Biology on Natural Killer Cancer Immunotherapy INKmune in the Journa...
Macroaxis News: globenewswire.com
over six months ago at news.google.com         
Trading With Integrated Risk Controls - Stock Traders Daily
Google News at Macroaxis
over six months ago at news.google.com         
Inmune Bio re-elects directors, ratifies auditor - Investing.com
Google News at Macroaxis
over six months ago at news.google.com         
INmune Bio, Inc. Short Interest Up 7.5 percent in June - American Banking and Market News
Google News at Macroaxis
over six months ago at news.google.com         
Janney Montgomery Scott LLC Decreases Stock Holdings in INmune Bio, Inc. - Defense World
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Shareholders Will Probably Be Cautious Of Increasing INmune Bio, Inc.s CEO Compensation At The Momen...
Yahoo News
Far too much social signal, news, headlines, and media speculation about INmune Bio that are available to investors today. That information is available publicly through INmune media outlets and privately through word of mouth or via INmune internal channels. However, regardless of the origin, that massive amount of INmune data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of INmune Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of INmune Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to INmune Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive INmune Bio alpha.

INmune Bio Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for INmune Stock analysis

When running INmune Bio's price analysis, check to measure INmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INmune Bio is operating at the current time. Most of INmune Bio's value examination focuses on studying past and present price action to predict the probability of INmune Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INmune Bio's price. Additionally, you may evaluate how the addition of INmune Bio to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Technical Analysis
Check basic technical indicators and analysis based on most latest market data